This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you are a person with diabetes, or would like more information on diabetes, please refer to our partner charity, the Diabetes Research & Wellness Foundation (DRWF).

Visit Charity?

Join the DPC Summer Forum - ADA in Practice

cpd certifiedThe DPC Summer Forum - ADA into practice will decipher the main outcomes from the ADA Scientific Conference.
We are really excited to be producing this series of digital panel sessions designed for all healthcare professionals from the diabetes MDT - in line with Diabetes Professional Care’s core objective of bringing together the entire diabetes healthcare community. 

The Summer Forum will be a CPD accredited, free to access digital series of five online sessions made up of interactive panel discussions and debates with leading UK KOLs.

Accompanying educational resources will support healthcare professionals in translating ADA outcomes into best practice, and ultimately better patient care and outcomes.

Kindly supported by: 

astra

Astra Zeneca have supported the DPC Summer Forum through an unrestricted grant and have no influence on the faculty or content.

 

 

 

Session 1/5: Post ADA round-up

Description

24th June - 7pm to 8pm 

This live webinar covered key take-home messages from the recent virtual ADA 2020 congress to help improve care for people living with diabetes.  Our expert diabetes multidisciplinary panel spanning primary and secondary care will distilled their main learning points from the congress as well as discussing how this learning might be implemented into day-to-day clinical practice. 

MDT Panel

  • Dr. Kevin Fernando (Chair) GP Partner & Medical Education & Scottish Lead
  • Dr. David Strain Clinical Senior Lecturer, Diabetes and Vascular Research Centre
  • Dr. Patrick Holmes GPwSI Diabetes
  • Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
  • Philip Newland-Jones Consultant Pharmacist Diabetes & Endocrinology Clinical Director Diabetes & Endocrinology

 

To access the recording, simply fill out the form on the right and you will be redirected to the page hosting all webinar recordings currently available. 

Recording

Session 2/5: SGLT2s VERTIS - a Class Effect?

Description

1st July - 7pm to 8pm

This live webinar will covered key take-home messages from the recent virtual ADA 2020 congress focusing on the latest SGLT2 inhibitor CV outcomes trial VERTIS CV (ertugliflozin) – are the benefits of SGLT2 inhibitors a class effect?  Our expert diabetes multidisciplinary panel, spanning primary and secondary care, distil their main learning points from VERTIS-CV as well as discussing how this learning might be implemented into day-to-day clinical practice

PANEL:

  • Dr. David Strain Clinical Senior Lecturer, Diabetes and Vascular Research Centre
  • Dr Derek Connnolly – Consultant Interventional Cardiologist
  • Dr Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society
  • Dr. Marc Evans Consultant Diabetologist
  • Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
  • Dr Patrick Holmes, GPwSI Diabetes
  • Hannah Beba, Senior Pharmacist Diabetes and Endocrinology

 

To access the recording, simply fill out the form on the right and you will be redirected to the page hosting all webinar recordings currently available. 

Recording 

Session 3/5: GLP1 ADA Round up

8th July - 7pm to 8pm

This live webinar will cover key take-home messages from the recent virtual ADA 2020 congress focusing on the GLP1 receptor agonist class of antihyperglycaemic medication.  Our expert diabetes multidisciplinary panel spanning primary and secondary care will distil their main learning points from key ADA2020 GLP1RA sessions as well as discussing how this learning might be implemented into day-to-day clinical practice

Main Learning Outcomes

  • How do GLP1 receptor agonists provide cardioprotection?
  • Primary cardiovascular prevention with GLP1 receptor agonists
  • GLP1 receptor agonists and retinopathy outcomes
  • How guidelines have changed to support the use of GLP1 receptor agonists
  • Why do GLP1 receptor agonists remain underused in the UK?

 

REGISTER HERE

Panel

  • Dr. David Strain (chair) Clinical Senior Lecturer, Diabetes and Vascular Research Centre
  • Dr. Patrick Holmes GPwSI
  • Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
  • Dr. Marc Evans Consultant Diabetologist
  • Victoria Ruszala, Specialist Diabetes and Endocrine Pharmacist 

Session 4/5: DAPA-HF – ADA update and prescribing in practice – Panel

​​​​​​15th July -  7pm to 8pm

This live webinar will cover key take-home messages from the recent virtual ADA 2020 congress focusing on the ground-breaking DAPA-HF study – the first positive SGLT2 inhibitor study with dedicated heart failure outcomes.  Our expert diabetes multidisciplinary panel spanning primary and secondary care will distil their main learning points from DAPA-HF as well as discussing how this learning might be implemented into day-to-day clinical practice

Main Learning Outcomes

  • Epidemiology & interaction of type 2 diabetes & heart failure
  • Effects of hyperglycaemic medications on heart failure outcomes
  • Key findings from DAPA-HF
  • Practicalities of using dapagliflozin in heart failure – do we need to titrate other heart failure medications?
  • How guidelines have changed to support the use of SGLT2 inhibitors in heart failure?

REGISTER HERE

Speakers:

  • Dr. David Strain (chair) Clinical Senior Lecturer, Diabetes and Vascular Research Centre
  • Prof John McMurray Professor of Cardiology, Lead Author DAPA-HF
  • Dr. Marc Evans Consultant Diabetologist
  • Prof. Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society
  • Philip Newland-Jones Consultant Pharmacist Diabetes & Endocrinology Clinical Director Diabetes & Endocrinology
  • Amanda Epps,  Diabetes Specialist Nurse
  • Dr. Kevin Fernando  GP Partner & Medical Education & Scottish Lead

Session 5/5: Hidden Burden of Hyperkalemia – Panel

21st July - 7pm to 8pm

REGISTER HERE

Panel

SPEAKER TO BE CONFIRMED!

Twitter

Sponsors

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Abbott

 

Gold & Wifi Sponsor

  • GlucoRX

 

Gold Sponsor

  • Roche

 

Gold Sponsor

  • Insulet

 

The InterACT Diabetes Village

  • AstraZeneca

 

Registration Sponsor

  • Diabetes Research & Wellness Foundation

 

Partners

Event Partner

  • NHS

Event Partner

  • ABCD

Event Partner

  • Diabetes Times

Event Partner

  • Trend

Media Partner

  • Caring Uk

Media Partner

  • Care Hub

Media Partner

  • Lifestyle Hub

Media Partner

  • Hospital Hub

Media Partner

  • Hub News

Media Partner

  • Practical Diabetes

Media Partner

  • Prescriber